List view / Grid view
21 April 2011 | By Merck
Combination vaccine designed to help protect against 6 diseases: diphtheria, tetanus, whooping cough, polio, Haemophilus influenzae type b, and hepatitis B...
21 April 2011 | By Harvard School of Public Health (HSPH)
Researchers have identified several genes that may be implicated in the malaria parasite's ability to rapidly evade drug treatments...
21 April 2011 | By The Scott Partnership
Molecular Profiles awarded Queen's Award for its nanoPASST service platform...
20 April 2011 | By Pfizer
Shanghai Pharmaceutical Co. Ltd. and Pfizer Inc. today announced the signing of a MOU...
20 April 2011 | By Gilead Sciences
Gilead & MicroDose Therapeutx have entered into an exclusive worldwide license...
20 April 2011 | By Roche
Roche announced that the FDA has approved the cobas HPV (Human Papillomavirus) Test...
19 April 2011 | By Abbott
Abbott announced that Miles D. White has been elected to the American Academy of Arts and Sciences...
19 April 2011 | By Biogen Idec
Genentech, and Biogen Idec announced today that the FDA approved Rituxan® (rituximab)...
18 April 2011 | By Expo Technologies LLC
Expo Technologies and Umetrics Inc. announce the release of Expo’s NovaMath 5.0...
18 April 2011 | By analytikLtd
Analytik release PHARMA•IDTM throughout Europe, the smallest, lightest, most cost-effective solution for rapid non-destructive raw material identification...
18 April 2011 | By Velvet Communications
Aesica Pharmaceuticals was named the 51st most profitable British company in the Sunday Times PwC Profit Track 100...
15 April 2011 | By Alto Marketing Limited
At the SBS conference, TTP LabTech announced collaboration with a world leader in membrane protein crystallography...
15 April 2011 | By Pfizer
Pfizer Inc. announced top-line results from the ORAL Scan Phase 3 study (A3921044)...
15 April 2011 | By Merck
Merck and Johnson & Johnson and its subsidiary Centocor Ortho Biotech Inc., announced that the companies have reached an agreement...
15 April 2011 | By Merck
Merck announced the commencement of the tender offer for all outstanding shares of Inspire Pharmaceuticals, Inc. for $5.00 per share...
